相关实验视频
Updated: Jun 27, 2025

09:48
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
357
基于mRNA的治疗策略用于癌症治疗
Thilelli Taibi1, Sehyun Cheon2, Fabiana Perna3
1Terry Fox Laboratory, British Columbia Cancer Research Institute, University of British Columbia, Vancouver, BC, Canada; Interdisciplinary Oncology Program, University of British Columbia, Vancouver, BC, Canada.
概括
使者RNA (mRNA) 疗法为癌症等疾病提供了精确的向. 最近的进展突显了它们的潜力,但这些基于RNA的新型干预措施在交付,有效性和安全性方面仍然存在挑战.
科学领域:
- 生物技术是生物技术.
- 分子医学是分子医学.
- 治疗开发的治疗方法
背景情况:
- 基于RNA的疗法,特别是信使RNA (mRNA),由于其适应性和精度,正在彻底改变医学研究.
- 随着COVID-19的流行,治疗干预的mRNA平台的开发和验证加速了.
- 这些方法提供了改变基因表达和细胞功能的潜力,用于治疗各种疾病.
研究的目的:
- 审查癌症治疗mRNA疗法的最新进展.
- 专注于当前基于RNA的干预措施的特点.
- 讨论临床前和临床发展,并确定剩余的挑战.
主要方法:
- 关于mRNA疗法的最新进展的文献综述.
- 分析使用的基于RNA的治疗干预措施.
- 检查临床前和临床试验数据.
主要成果:
- mRNA疗法在重塑向治疗的基因表达方面显示出显著的潜力.
- 该综述涵盖了各种基于RNA的干预措施,包括它们在瘤学中的特征和应用.
- 目前的临床前和临床发展有希望,但强调了正在进行的研究需求.
结论:
- mRNA疗法代表了医学上的范式转变,提供了个性化的治疗策略.
- 需要进一步的研究,以克服广泛临床应用的交付,有效性和安全性方面的挑战.
- RNA技术的进步为治疗遗传疾病,癌症和传染病提供了希望.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K

